hypothesized that the Horizons Program would be feasible based on enrollment, attendance, and retention (primary outcomes). We also explored intervention effects on QoL, symptom burden, and anxiety and depression symptoms (secondary outcomes), as well as on
Search Results
Group Coping Intervention in Patients With Chronic Graft-Versus-Host Disease: A Pilot Randomized Clinical Trial
Ashley M. Nelson, Daniel Yang, Annemarie D. Jagielo, Jennifer D’Alotto, Cathleen Poliquin, Dustin J. Rabideau, Katherine G. Cronin, Richard A. Newcomb, Yi-Bin Chen, Zachariah DeFilipp, Joseph A. Greer, Areej El-Jawahri, and Lara Traeger
Randomized Trial of a Smartphone Mobile App to Improve Symptoms and Adherence to Oral Therapy for Cancer
Joseph A. Greer, Jamie M. Jacobs, Nicole Pensak, Lauren E. Nisotel, Joel N. Fishbein, James J. MacDonald, Molly E. Ream, Emily A. Walsh, Joanne Buzaglo, Alona Muzikansky, Inga T. Lennes, Steven A. Safren, William F. Pirl, and Jennifer S. Temel
(MMAS-4), symptom burden, QoL, satisfaction with treatment, and healthcare utilization did not differ significantly between groups ( Table 2 ). Table 2. Study Group Differences in Primary and Secondary Outcomes Moderation Effects on Adherence Outcome As
Patient-Reported Distress in Myelodysplastic Syndromes and Its Association With Clinical Outcomes: A Retrospective Cohort Study
Jesse D. Troy, Carlos M. de Castro, Mary Ruth Pupa, Greg P. Samsa, Amy P. Abernethy, and Thomas W. LeBlanc
-reported distress in ambulatory patients with MDS visiting a Comprehensive Cancer Center. First, these patients have a relatively high burden of distress, with physical symptoms representing the most frequently reported issue, and a greater overall symptom burden in
Priority Rankings of Patient-Reported Outcomes for Pancreatic Ductal Adenocarcinoma: A Comparison of Patient and Physician Perspectives
Michelle Guan, Gillian Gresham, Arvind Shinde, Isaac Lapite, Jun Gong, Veronica R. Placencio-Hickok, Christopher B. Forrest, and Andrew E. Hendifar
care, the severity of treatment-related impairments that later develop may be reduced, which is especially relevant to a high–symptom burden disease such as PDAC. Further research on the feasibility of incorporating PROs in pancreatic cancer care is
Chemotherapy-Induced Peripheral Neurotoxicity in Cancer Survivors: Predictors of Long-Term Patient Outcomes
Eva Battaglini, David Goldstein, Peter Grimison, Susan McCullough, Phil Mendoza-Jones, and Susanna B. Park
validated measures to assess CIPN, QoL, and physical activity. We aimed to investigate the impacts associated with CIPN symptom burden on the lives of cancer survivors across a range of domains, examining symptoms over time and interactions with other
HSR24-124: Determinants of Quality of Life and Optimism in Patients With EGFR Mutated Advanced Non–Small Cell Lung Cancer
Elizabeth Marrett, Shaloo Gupta, Kushal Modi, Song Li, Jillian Rowen, and Jackie Kwong
associated with Asian race, having a caregiver, and higher NSCLC symptom burden (all P <.05). Conclusion: Efficacious treatments that improve patient expectations and satisfaction with therapy, reduce NSCLC symptoms, and prolong progression-free survival
HSR24-166: Implementation of an Integrated Supportive Care Medicine Consultation Service Within a Gastrointestinal Cancer Clinic: Timeliness of Referrals and Patient Access
Dena Berhan, Nicole Nardella, Adrianna Oraiqat, Denny Lu, Sarah Goodchild, Terry Gruchow, Young Chang, Sahana Rajasekhara, and Pamela Hodul
-narcotic pain management remained the same. GI malignancies frequently present with advanced cancers and high symptom burden. Improved access to SCM has been associated with improved quality of life (QOL) and increased survival. (Temel et al, 2010, 2017) Here we
HSR24-167: Improved Access Through an Integrated Supportive Care Model Reduced Urgent Care Referral and Admission Rates for Patients With Gastrointestinal Malignancy
Adrianna Oraiqat, Nicole Nardella, Dena Berhan, Denny Lu, Sarah Goodchild, Terry Gruchow, Young Chang, Sahana Rajasekhara, and Pamela Hodul
Background: Gastrointestinal (GI) malignancies frequently present with high symptom burden making Supportive Care Medicine (SCM) an integral component of patient care. Previous institutional work demonstrated that an integrated SCM model within
QIM21-084: Perceived Needs and Patient Satisfaction of Psychosocial Distress Screening and Management in Inpatient Hematology Oncology Specialty Care
Chao-Hui Sylvia Huang, Jennifer K. Anderson, Jasmine A. Boykin, Jasmine K. Vickers, Heather Forbes, Kellie L. Flood, Lisle M. Nabell, and Kelly N. Godby
strategies to manage anxiety or depression. Barriers to receive counseling services include physical symptom burden such as pain and fatigue, medical procedures, and inadequate psychosocial care staffing. Findings revealed high perceived needs and patient
BPI22-020: Better Together: Why Palliative Care Should be Incorporated Early in Patients With Advanced Head and Neck Cancer
Vishal Kapadia, Elisa Griswold, Kelley Newcomer, Brittny Tillman, Jane Mwangi, and Stephanie Terauchi
Background : Advanced head and neck cancers often necessitate intensive treatment regimens in pursuit of a cure. These cancers and their treatments frequently lead to significant symptom burden, impacting many patients’ overall quality of life
